The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Azuma, M.
Right arrow Articles by Lanier, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Azuma, M.
Right arrow Articles by Lanier, L. L.

The Journal of Immunology, Vol 150, Issue 4 1147-1159, Copyright © 1993 by American Association of Immunologists

ARTICLES

CD28- T lymphocytes. Antigenic and functional properties

M Azuma, JH Phillips and LL Lanier
DNAX Research Institute of Molecular and Cellular Biology, Department of Immunology, Palo Alto, CA 94304.

A subset of CD8+ alpha beta-TCR/CD3+ T lymphocytes in adult human peripheral blood lacks expression of CD28, a membrane receptor for the B7/BB1 B cell differentiation Ag that is involved in T cell activation. CD28-8+ T cells were not observed in the thymus and were present at only low frequency in cord blood, suggesting that these cells may represent a type of "memory" population. Consistent with this interpretation, CD28-8+ T cells were morphologically large, granular lymphocytes and expressed CD54 (intercellular adhesion molecule-1), CD58 (lymphocyte function-associated Ag-3 (LFA)), and high levels of CD11a (LFA-1), but did not express Ag associated with acute activation (e.g., HLA-DR, CD25, CD69). Freshly isolated CD28-8+ T lymphocytes mediated potent anti-CD3 redirected cytotoxicity against FcR-bearing targets, demonstrating that the CD3/TCR complex is functional and that these cells possess cytolytic activity. However, the anti-CD3-induced proliferative response of CD28-8+ T cells was substantially less than CD28+8+ T cells and this deficiency could not be overcome by addition of exogenous IL-2. A large panel of T cell clones were produced from the CD28+8+ and CD28-8+ T cell populations by single cell sorting using a flow cytometer. CD28 expression was stable on clones derived from CD28+8+ T lymphocytes, whereas CD28 expression was quite variable and apparently reexpressed on some clones generated from the CD28-8+ T cell population. As with the freshly isolated cells, CD28-8+ T cell clones were cytotoxic, but anergic to anti-CD3- induced proliferation and could not be costimulated using B7 or CD58 (LFA-3) murine L cell transfectants. These results indicate that CD28- and CD28+ T cells may play different roles in an immune response.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
H. Zhang, K. M. Snyder, M. M. Suhoski, M. V. Maus, V. Kapoor, C. H. June, and C. L. Mackall
4-1BB Is Superior to CD28 Costimulation for Generating CD8+ Cytotoxic Lymphocytes for Adoptive Immunotherapy
J. Immunol., October 1, 2007; 179(7): 4910 - 4918.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Barbey, P. Baumgaertner, E. Devevre, V. Rubio-Godoy, L. Derre, G. Bricard, P. Guillaume, I. F. Luescher, D. Lienard, J.-C. Cerottini, et al.
IL-12 Controls Cytotoxicity of a Novel Subset of Self-Antigen-Specific Human CD28+ Cytolytic T Cells
J. Immunol., March 15, 2007; 178(6): 3566 - 3574.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. K. Chiu, M. Fann, and N.-p. Weng
Generation and Growth of CD28nullCD8+ Memory T Cells Mediated by IL-15 and Its Induced Cytokines
J. Immunol., December 1, 2006; 177(11): 7802 - 7810.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Vidric, W.-K. Suh, U. Dianzani, T. W. Mak, and T. H. Watts
Cooperation between 4-1BB and ICOS in the Immune Response to Influenza Virus Revealed by Studies of CD28/ICOS-Deficient Mice
J. Immunol., December 1, 2005; 175(11): 7288 - 7296.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Thimme, V. Appay, M. Koschella, E. Panther, E. Roth, A. D. Hislop, A. B. Rickinson, S. L. Rowland-Jones, H. E. Blum, and H. Pircher
Increased Expression of the NK Cell Receptor KLRG1 by Virus-Specific CD8 T Cells during Persistent Antigen Stimulation
J. Virol., September 15, 2005; 79(18): 12112 - 12116.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Davila, Y. M. Kang, Y. W. Park, H. Sawai, X. He, S. Pryshchep, J. J. Goronzy, and C. M. Weyand
Cell-Based Immunotherapy with Suppressor CD8+ T Cells in Rheumatoid Arthritis
J. Immunol., June 1, 2005; 174(11): 7292 - 7301.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
I. Mende, P. Hoffmann, A. Wolf, R. Lutterbuse, E. Kopp, P. A. Baeuerle, A. de Baey, and P. Kufer
Highly efficient antigen targeting to M-DC8+ dendritic cells via Fc{gamma}RIII/CD16-specific antibody conjugates
Int. Immunol., May 1, 2005; 17(5): 539 - 547.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. I. R. Ehrlich, K. Ogasawara, J. A. Hamerman, R. Takaki, A. Zingoni, J. P. Allison, and L. L. Lanier
Engagement of NKG2D by Cognate Ligand or Antibody Alone Is Insufficient to Mediate Costimulation of Human and Mouse CD8+ T Cells
J. Immunol., February 15, 2005; 174(4): 1922 - 1931.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. J. Powell Jr, M. E. Dudley, P. F. Robbins, and S. A. Rosenberg
Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy
Blood, January 1, 2005; 105(1): 241 - 250.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y.-J. Kim, T. M. Stringfield, Y. Chen, and H. E. Broxmeyer
Modulation of cord blood CD8+ T-cell effector differentiation by TGF-{beta}1 and 4-1BB costimulation
Blood, January 1, 2005; 105(1): 274 - 281.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
G. Borkow and Z. Bentwich
Chronic Immune Activation Associated with Chronic Helminthic and Human Immunodeficiency Virus Infections: Role of Hyporesponsiveness and Anergy
Clin. Microbiol. Rev., October 1, 2004; 17(4): 1012 - 1030.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
J. A. DeVoti, B. M. Steinberg, D. W. Rosenthal, L. Hatam, A. Vambutas, A. L. Abramson, M. J. Shikowitz, and V. R. Bonagura
Failure of Gamma Interferon but Not Interleukin-10 Expression in Response to Human Papillomavirus Type 11 E6 Protein in Respiratory Papillomatosis
Clin. Vaccine Immunol., May 1, 2004; 11(3): 538 - 547.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
A. Canton, E. M. Martinez-Caceres, C. Hernandez, C. Espejo, J. Garcia-Arumi, and R. Simo
CD4-CD8 and CD28 Expression in T Cells Infiltrating the Vitreous Fluid in Patients With Proliferative Diabetic Retinopathy: A Flow Cytometric Analysis
Arch Ophthalmol, May 1, 2004; 122(5): 743 - 749.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. R. Conejo-Garcia, F. Benencia, M. C. Courreges, P. A. Gimotty, E. Khang, R. J. Buckanovich, K. A. Frauwirth, L. Zhang, D. Katsaros, C. B. Thompson, et al.
Ovarian Carcinoma Expresses the NKG2D Ligand Letal and Promotes the Survival and Expansion of CD28- Antitumor T Cells
Cancer Res., March 15, 2004; 64(6): 2175 - 2182.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Rothenfusser, V. Hornung, M. Ayyoub, S. Britsch, A. Towarowski, A. Krug, A. Sarris, N. Lubenow, D. Speiser, S. Endres, et al.
CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8+ T-cell responses in vitro
Blood, March 15, 2004; 103(6): 2162 - 2169.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
A. Ortiz-Suarez and R. A. Miller
Antigen-Independent Expansion of CD28hi CD8 Cells From Aged Mice: Cytokine Requirements and Signal Transduction Pathways
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2003; 58(12): B1063 - 1073.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
V. Jankovic, I. Messaoudi, and J. Nikolich-Zugich
Phenotypic and functional T-cell aging in rhesus macaques (Macaca mulatta): differential behavior of CD4 and CD8 subsets
Blood, November 1, 2003; 102(9): 3244 - 3251.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
M. S. Topp, S. R. Riddell, Y. Akatsuka, M. C. Jensen, J. N. Blattman, and P. D. Greenberg
Restoration of CD28 Expression in CD28- CD8+ Memory Effector T Cells Reconstitutes Antigen-induced IL-2 Production
J. Exp. Med., September 15, 2003; 198(6): 947 - 955.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
E. Amyes, C. Hatton, D. Montamat-Sicotte, N. Gudgeon, A. B. Rickinson, A. J. McMichael, and M. F.C. Callan
Characterization of the CD4+ T Cell Response to Epstein-Barr Virus during Primary and Persistent Infection
J. Exp. Med., September 15, 2003; 198(6): 903 - 911.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
W. J. M. Mackus, F. N. J. Frakking, A. Grummels, L. E. Gamadia, G. J. de Bree, D. Hamann, R. A. W. van Lier, and M. H. J. van Oers
Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia
Blood, August 1, 2003; 102(3): 1057 - 1063.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Geginat, A. Lanzavecchia, and F. Sallusto
Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines
Blood, June 1, 2003; 101(11): 4260 - 4266.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. M. Aandahl, J. K. Sandberg, K. P. Beckerman, K. Tasken, W. J. Moretto, and D. F. Nixon
CD7 Is a Differentiation Marker That Identifies Multiple CD8 T Cell Effector Subsets
J. Immunol., March 1, 2003; 170(5): 2349 - 2355.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Ayyoub, A. Zippelius, M. J. Pittet, D. Rimoldi, D. Valmori, J.-C. Cerottini, P. Romero, F. Lejeune, D. Lienard, and D. E. Speiser
Activation of Human Melanoma Reactive CD8+ T Cells by Vaccination with an Immunogenic Peptide Analog Derived from Melan-A/Melanoma Antigen Recognized by T Cells-1
Clin. Cancer Res., February 1, 2003; 9(2): 669 - 677.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. M. van Leeuwen, L. E. Gamadia, P. A. Baars, E. B. Remmerswaal, I. J. ten Berge, and R. A. van Lier
Proliferation Requirements of Cytomegalovirus-Specific, Effector-Type Human CD8+ T Cells
J. Immunol., November 15, 2002; 169(10): 5838 - 5843.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Voehringer, M. Koschella, and H. Pircher
Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1)
Blood, November 15, 2002; 100(10): 3698 - 3702.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y.-J. Kim, R. R. Brutkiewicz, and H. E. Broxmeyer
Role of 4-1BB (CD137) in the functional activation of cord blood CD28-CD8+ T cells
Blood, October 16, 2002; 100(9): 3253 - 3260.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Khan, N. Shariff, M. Cobbold, R. Bruton, J. A. Ainsworth, A. J. Sinclair, L. Nayak, and P. A. H. Moss
Cytomegalovirus Seropositivity Drives the CD8 T Cell Repertoire Toward Greater Clonality in Healthy Elderly Individuals
J. Immunol., August 15, 2002; 169(4): 1984 - 1992.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Tomiyama, T. Matsuda, and M. Takiguchi
Differentiation of Human CD8+ T Cells from a Memory to Memory/Effector Phenotype
J. Immunol., June 1, 2002; 168(11): 5538 - 5550.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. E. Speiser, M. Colonna, M. Ayyoub, M. Cella, M. J. Pittet, P. Batard, D. Valmori, P. Guillaume, D. Lienard, J.-C. Cerottini, et al.
The Activatory Receptor 2B4 Is Expressed In Vivo by Human CD8+ Effector {alpha}{beta} T Cells
J. Immunol., December 1, 2001; 167(11): 6165 - 6170.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Suresh, J. K. Whitmire, L. E. Harrington, C. P. Larsen, T. C. Pearson, J. D. Altman, and R. Ahmed
Role of CD28-B7 Interactions in Generation and Maintenance of CD8 T Cell Memory
J. Immunol., November 15, 2001; 167(10): 5565 - 5573.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Nishio, M. Suzuki, N. Miyasaka, and H. Kohsaka
Clonal Biases of Peripheral CD8 T Cell Repertoire Directly Reflect Local Inflammation in Polymyositis
J. Immunol., October 1, 2001; 167(7): 4051 - 4058.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. D. Hislop, N. H. Gudgeon, M. F. C. Callan, C. Fazou, H. Hasegawa, M. Salmon, and A. B. Rickinson
EBV-Specific CD8+ T Cell Memory: Relationships Between Epitope Specificity, Cell Phenotype, and Immediate Effector Function
J. Immunol., August 15, 2001; 167(4): 2019 - 2029.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
D. T. Fearon, P. Manders, and S. D. Wagner
Arrested Differentiation, the Self-Renewing Memory Lymphocyte, and Vaccination
Science, July 13, 2001; 293(5528): 248 - 250.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Fong, Y. Hou, A. Rivas, C. Benike, A. Yuen, G. A. Fisher, M. M. Davis, and E. G. Engleman
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
PNAS, June 20, 2001; (2001) 141226398.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. J. Pittet, A. Zippelius, D. E. Speiser, M. Assenmacher, P. Guillaume, D. Valmori, D. Lienard, F. Lejeune, J.-C. Cerottini, and P. Romero
Ex Vivo IFN-{{gamma}} Secretion by Circulating CD8 T Lymphocytes: Implications of a Novel Approach for T Cell Monitoring in Infectious and Malignant Diseases
J. Immunol., June 15, 2001; 166(12): 7634 - 7640.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
D F Dukers, M H Vermeer, L H Jaspars, C A Sander, M J Flaig, W Vos, R Willemze, and C J L M Meijer
Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype
J. Clin. Pathol., March 1, 2001; 54(3): 224 - 228.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Fiorentini, S. Licenziati, G. Alessandri, F. Castelli, S. Caligaris, M. Bonafede, M. Grassi, E. Garrafa, A. Balsari, A. Turano, et al.
CD11b Expression Identifies CD8+CD28+ T Lymphocytes with Phenotype and Function of Both Naive/Memory and Effector Cells
J. Immunol., January 15, 2001; 166(2): 900 - 907.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Storek, G. Espino, M. A. Dawson, B. Storer, M. E. D. Flowers, and D. G. Maloney
Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation
Blood, November 1, 2000; 96(9): 3290 - 3293.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
J. Wu, H. Cherwinski, T. Spies, J. H. Phillips, and L. L. Lanier
DAP10 and DAP12 Form Distinct, but Functionally Cooperative, Receptor Complexes in Natural Killer Cells
J. Exp. Med., October 2, 2000; 192(7): 1059 - 1068.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. A. Baars, L. M. Ribeiro do Couto, J. H. W. Leusen, B. Hooibrink, T. W. Kuijpers, S. M. A. Lens, and R. A. W. van Lier
Cytolytic Mechanisms and Expression of Activation-Regulating Receptors on Effector-Type CD8+CD45RA+CD27- Human T Cells
J. Immunol., August 15, 2000; 165(4): 1910 - 1917.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. H. Son, S. Murray, J. Yanovski, R. J. Hodes, and N.-p. Weng
Lineage-Specific Telomere Shortening and Unaltered Capacity for Telomerase Expression in Human T and B Lymphocytes with Age
J. Immunol., August 1, 2000; 165(3): 1191 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
N. J. Borthwick, M. Lowdell, M. Salmon, and A. N. Akbar
Loss of CD28 expression on CD8+ T cells is induced by IL-2 receptor {gamma} chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis
Int. Immunol., July 1, 2000; 12(7): 1005 - 1013.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
F. F. Fagnoni, R. Vescovini, G. Passeri, G. Bologna, M. Pedrazzoni, G. Lavagetto, A. Casti, C. Franceschi, M. Passeri, and P. Sansoni
Shortage of circulating naive CD8+ T cells provides new insights on immunodeficiency in aging
Blood, May 1, 2000; 95(9): 2860 - 2868.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. J. Pittet, D. E. Speiser, D. Valmori, J.-C. Cerottini, and P. Romero
Cutting Edge: Cytolytic Effector Function in Human Circulating CD8+ T Cells Closely Correlates with CD56 Surface Expression
J. Immunol., February 1, 2000; 164(3): 1148 - 1152.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
C. L. Mackall
T-Cell Immunodeficiency Following Cytotoxic Antineoplastic Therapy: A Review
Stem Cells, January 1, 2000; 18(1): 10 - 18.
[Abstract] [Full Text]

Home page
 The OncologistHome page
C. L. Mackall
T-Cell Immunodeficiency Following Cytotoxic Antineoplastic Therapy: A Review
Oncologist, October 1, 1999; 4(5): 370 - 378.
[Abstract] [Full Text]

Home page
 JEMHome page
D. E. Speiser, M. J. Pittet, D. Valmori, R. Dunbar, D. Rimoldi, D. Lienard, H. R. MacDonald, J.-C. Cerottini, V. Cerundolo, and P. Romero
In Vivo Expression of Natural Killer Cell Inhibitory Receptors by Human Melanoma–specific Cytolytic T Lymphocytes
J. Exp. Med., September 20, 1999; 190(6): 775 - 782.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
M. J. Pittet, D. Valmori, P. R. Dunbar, D. E. Speiser, D. Lienard, F. Lejeune, K. Fleischhauer, V. Cerundolo, J.-C. Cerottini, and P. Romero
High Frequencies of Naive Melan-A/MART-1–specific CD8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (HLA)-A2 Individuals
J. Exp. Med., September 6, 1999; 190(5): 705 - 716.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
M. Labalette, E. Leteurtre, C. Thumerelle, C. Grutzmacher, B. Tourvieille, and J.-P. Dessaint
Peripheral human CD8+CD28+T lymphocytes give rise to CD28–progeny, but IL-4 prevents loss of CD28 expression
Int. Immunol., August 1, 1999; 11(8): 1327 - 1336.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Akiba, H. Oshima, K. Takeda, M. Atsuta, H. Nakano, A. Nakajima, C. Nohara, H. Yagita, and K. Okumura
CD28-Independent Costimulation of T Cells by OX40 Ligand and CD70 on Activated B Cells
J. Immunol., June 15, 1999; 162(12): 7058 - 7066.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Peritt, D. A. Sesok-Pizzini, R. Schretzenmair, R. R. Macgregor, N. M. Valiante, X. Tu, G. Trinchieri, and M. Kamoun
C1.7 Antigen Expression on CD8+ T Cells Is Activation Dependent: Increased Proportion of C1.7+CD8+ T Cells in HIV-1-Infected Patients with Progressing Disease
J. Immunol., June 15, 1999; 162(12): 7563 - 7568.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. P. Weekes, A. J. Carmichael, M. R. Wills, K. Mynard, and J. G. P. Sissons
Human CD28-CD8+ T Cells Contain Greatly Expanded Functional Virus-Specific Memory CTL Clones
J. Immunol., June 15, 1999; 162(12): 7569 - 7577.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Meyaard, J. Hurenkamp, H. Clevers, L. L. Lanier, and J. H. Phillips
Leukocyte-Associated Ig-Like Receptor-1 Functions as an Inhibitory Receptor on Cytotoxic T Cells
J. Immunol., May 15, 1999; 162(10): 5800 - 5804.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. M. Nociari, W. Telford, and C. Russo
Postthymic Development of CD28-CD8+ T Cell Subset: Age-Associated Expansion and Shift from Memory to Naive Phenotype
J. Immunol., March 15, 1999; 162(6): 3327 - 3335.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. J. Kuroda, J. E. Schmitz, W. A. Charini, C. E. Nickerson, C. I. Lord, M. A. Forman, and N. L. Letvin
Comparative Analysis of Cytotoxic T Lymphocytes in Lymph Nodes and Peripheral Blood of Simian Immunodeficiency Virus-Infected Rhesus Monkeys
J. Virol., February 1, 1999; 73(2): 1573 - 1579.
[Abstract] [Full Text]

Home page
 Int ImmunolHome page
D. N. Posnett, J. W. Edinger, J. S. Manavalan, C. Irwin, and G. Marodon
Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+CD28– cytotoxic effector clones
Int. Immunol., February 1, 1999; 11(2): 229 - 241.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. G. Tangye, J. H. Phillips, L. L. Lanier, J. E. de Vries, and G. Aversa
CD148: A Receptor-Type Protein Tyrosine Phosphatase Involved in the Regulation of Human T Cell Activation
J. Immunol., October 1, 1998; 161(7): 3249 - 3255.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Anumanthan, A. Bensussan, L. Boumsell, A. D. Christ, R. S. Blumberg, S. D. Voss, A. T. Patel, M. J. Robertson, L. M. Nadler, and G. J. Freeman
Cloning of BY55, a Novel Ig Superfamily Member Expressed on NK Cells, CTL, and Intestinal Intraepithelial Lymphocytes
J. Immunol., September 15, 1998; 161(6): 2780 - 2790.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Guillaume, D. B. Rubinstein, and M. Symann
Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell Transplantation
Blood, September 1, 1998; 92(5): 1471 - 1490.
[Full Text] [PDF]

Home page
 BloodHome page
J. E. Schmitz, M. A. Forman, M. A. Lifton, O. Concepcion Jr, K. A. Reimann, C. S. Crumpacker, J. F. Daley, R. S. G